Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Sep;10(3):555–563. doi: 10.1128/aac.10.3.555

Can Mannitol Reduce Amphotericin B Nephrotoxicity? Double-Blind Study and Description of a New Vascular Lesion in Kidneys

Ward E Bullock *, Robert G Luke *, Charles E Nuttall *, Dinyar Bhathena *
PMCID: PMC429787  PMID: 791105

Abstract

Eleven patients with systemic mycotic infections were treated with amphotericin B, 1 mg/kg, on alternate days. Five patients also received mannitol (M), 1 g/kg, in the amphotericin infusion, while six served as controls (C). Renal function studies prior to therapy were repeated at a total cumulative amphotericin B dosage of 25 mg/kg; renal biopsies were obtained from 10 patients. Inulin and creatinine clearances decreased in both the C and M groups, significantly so in the latter. Urinary concentrating ability of five patients (2C, 3M) decreased as did the capacity of three (1C, 2M) to acidify urine after an acid load. Neither the peak and valley levels of amphotericin B in serum nor the urinary excretion thereof differed between the C and M groups. Striking vacuolization of smooth muscle cells, previously unrecognized, was observed in the media of arterioles and arteries in all renal biopsies. Tubular calcification was present in both groups. In summary, M therapy (1 g/kg) did not protect against the nephrotoxicity of amphotericin B. A unique lesion of the renal vasculature secondary to amphotericin B is described.

Full text

PDF
561

Images in this article

559Image
on p.559
561Image
on p.561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreoli T. E. On the anatomy of amphotericin B-cholesterol pores in lipid bilayer membranes. Kidney Int. 1973 Nov;4(5):337–345. doi: 10.1038/ki.1973.126. [DOI] [PubMed] [Google Scholar]
  2. BELL N. H., ANDRIOLE V. T., SABESIN S. M., UTZ J. P. On the nephrotoxicity of amphotericin B in man. Am J Med. 1962 Jul;33:64–69. doi: 10.1016/0002-9343(62)90277-2. [DOI] [PubMed] [Google Scholar]
  3. BUTLER W. T., BENNETT J. E., ALLING D. W., WERTLAKE P. T., UTZ J. P., HILL G. J., 2nd NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS. Ann Intern Med. 1964 Aug;61:175–187. doi: 10.7326/0003-4819-61-2-175. [DOI] [PubMed] [Google Scholar]
  4. BUTLER W. T., HILL G. J., 2nd, SZWED C. F., KNIGHT V. AMPHOTERICIN B RENAL TOXICITY IN THE DOG. J Pharmacol Exp Ther. 1964 Jan;143:47–56. [PubMed] [Google Scholar]
  5. Bennett J. E. Chemotherapy of systemic mycoses (first of two parts). N Engl J Med. 1974 Jan 3;290(1):30–32. doi: 10.1056/NEJM197401032900107. [DOI] [PubMed] [Google Scholar]
  6. Burgess J. L., Birchall R. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Am J Med. 1972 Jul;53(1):77–84. [PubMed] [Google Scholar]
  7. Camishion R. C., Solit R. W., Iida J., Ballinger W. F., 2nd The effect of mannitol on renal vascular resistance. Surgery. 1966 Jun;59(6):1037–1042. [PubMed] [Google Scholar]
  8. Flores J., DiBona D. R., Beck C. H., Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest. 1972 Jan;51(1):118–126. doi: 10.1172/JCI106781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GOLDBERG A. H., LILIENFIELD L. S. EFFECTS OF HYPERTONIC MANNITOL ON RENAL VASCULAR RESISTANCE. Proc Soc Exp Biol Med. 1965 Jul;119:635–642. doi: 10.3181/00379727-119-30259. [DOI] [PubMed] [Google Scholar]
  10. Gennari F. J., Kassirer J. P. Osmotic diuresis. N Engl J Med. 1974 Oct 3;291(14):714–720. doi: 10.1056/NEJM197410032911408. [DOI] [PubMed] [Google Scholar]
  11. Gouge T. H., Andriole V. T. An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. J Lab Clin Med. 1971 Nov;78(5):713–724. [PubMed] [Google Scholar]
  12. HOLEMAN C. W., Jr, EINSTEIN H. The toxic effects of amphotericin B in man. Calif Med. 1963 Aug;99:90–93. [PMC free article] [PubMed] [Google Scholar]
  13. Hellebusch A. A., Salama F., Eadie E. The use of mannitol to reduce the nephrotoxicity of amphotericin B. Surg Gynecol Obstet. 1972 Feb;134(2):241–243. [PubMed] [Google Scholar]
  14. KULKA R. G. Colorimetric estimation of ketopentoses and ketohexoses. Biochem J. 1956 Aug;63(4):542–548. doi: 10.1042/bj0630542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LICHTENSTEIN N. S., LEAF A. EFFECT OF AMPHOTERICIN B ON THE PERMEABILITY OF THE TOAD BLADDER. J Clin Invest. 1965 Aug;44:1328–1342. doi: 10.1172/JCI105238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Luke R. G., Kennedy A. C. Prevention and early management of acute renal failure. Postgrad Med J. 1967 Apr;43(498):280–289. doi: 10.1136/pgmj.43.498.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McCurdy D. K., Frederic M., Elkinton J. R. Renal tubular acidosis due to amphotericin B. N Engl J Med. 1968 Jan 18;278(3):124–130. doi: 10.1056/NEJM196801182780302. [DOI] [PubMed] [Google Scholar]
  18. Miller R. P., Bates J. H. Amphotericin B toxicity. A follow-up report of 53 patients. Ann Intern Med. 1969 Dec;71(6):1089–1095. doi: 10.7326/0003-4819-71-6-1089. [DOI] [PubMed] [Google Scholar]
  19. Morris C. R., Alexander E. A., Bruns F. J., Levinsky N. G. Restoration and maintenance of glomerular filtration by mannitol during hypoperfusion of the kidney. J Clin Invest. 1972 Jun;51(6):1555–1564. doi: 10.1172/JCI106952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Olivero J. J., Lozano-Mendez J., Ghafary E. M., Eknoyan G., Suki W. N. Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J. 1975 Mar 8;1(5957):550–551. doi: 10.1136/bmj.1.5957.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shadomy S., McCay J. A., Schwartz S. I. Bioassay for hamycin and amphotericin B in serum and other biological fluids. Appl Microbiol. 1969 Apr;17(4):497–503. doi: 10.1128/am.17.4.497-503.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Steinmetz P. R., Lawson L. R. Defect in urinary acidification induced in vitro by amphotericin B. J Clin Invest. 1970 Mar;49(3):596–601. doi: 10.1172/JCI106270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. UTZ J. P. AMPHOTERICIN B TOXICITY; GENERAL SIDE EFFECTS. Ann Intern Med. 1964 Aug;61:340–343. doi: 10.7326/0003-4819-61-2-340. [DOI] [PubMed] [Google Scholar]
  24. WERTLAKE P. T., BUTLER W. T., HILL G. J., 2nd, UTZ J. P. NEPHROTOXIC TUBULAR DAMAGE AND CALCIUM DEPOSITION FOLLOWING AMPHOTERICIN B THERAPY. Am J Pathol. 1963 Sep;43:449–457. [PMC free article] [PubMed] [Google Scholar]
  25. WRONG O., DAVIES H. E. The excretion of acid in renal disease. Q J Med. 1959 Apr;28(110):259–313. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES